Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€8.93

€8.93

2.290%
0.2
2.290%
-
 
15:33 / Tradegate WKN: A0JEGY / Symbol: CLVLF / Name: Clinuvel Pharma / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Clinuvel Pharmaceuticals Stock

There is an upward development for Clinuvel Pharmaceuticals compared to yesterday, with an increase of €0.20 (2.290%).
Our community identified positive and negative aspects for Clinuvel Pharmaceuticals stock for the coming years. 1 users see the criterium "Valuation (undervalued/overvalued)" as a plus for the Clinuvel Pharmaceuticals stock. On the other hand our users think that "Customer and product portfolio" could be a problem in the future.

Pros and Cons of Clinuvel Pharmaceuticals in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Clinuvel Pharmaceuticals vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Clinuvel Pharmaceuticals 2.290% -3.324% 3.598% -28.101% -10.915% -54.956% -41.007%
Syros Pharmaceuticals Inc. -5.830% -15.248% -26.460% 79.832% -35.152% -91.925% -
Pharma Mar S.A. 1.070% -4.724% -7.118% -34.207% -36.132% -71.560% -
Starpharma Holdings Ltd. 0.710% 7.692% 3.704% -75.862% -25.926% -93.578% -91.587%

Comments

Buy Clinuvel Pharmaceuticals
Show more

Buy Clinuvel Pharmaceuticals
Show more

Buy Clinuvel Pharmaceuticals
Show more